1160P an Italian Multicenter Phase II Trial of Metronomic Temozolomide in Unfit Patients with Advanced Neuroendocrine Neoplasms: Interim Analysis of the MeTe Study
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined